These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

992 related articles for article (PubMed ID: 32483459)

  • 1. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
    Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
    Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale Copper(II)-Diethyldithiocarbamate Coordination Polymer as a Drug Self-Delivery System for Highly Robust and Specific Cancer Therapy.
    Peng Y; Liu P; Meng Y; Hu S; Ding J; Zhou W
    Mol Pharm; 2020 Aug; 17(8):2864-2873. PubMed ID: 32551674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer.
    Zhang H; Song F; Dong C; Yu L; Chang C; Chen Y
    J Nanobiotechnology; 2021 Sep; 19(1):290. PubMed ID: 34579711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper(II)-disulfiram loaded melanin-dots for cancer theranostics.
    Shi H; Suo Y; Zhang Z; Liu R; Liu H; Cheng Z
    Nanomedicine; 2021 Feb; 32():102340. PubMed ID: 33227540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Action of Acidic Microenvironment on the Enrichment of the Active Metabolite of Disulfiram in Tumor Tissues.
    Tang C; Pang X; Guo Z; Guo R; Liu L; Chen X
    Drug Metab Dispos; 2021 Jun; 49(6):434-441. PubMed ID: 33762296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy.
    Li Q; Chao Y; Liu B; Xiao Z; Yang Z; Wu Y; Liu Z
    Biomaterials; 2022 Dec; 291():121880. PubMed ID: 36334355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
    Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
    Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Tumor-Specific Disulfiram Chemotherapy by
    Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
    J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
    Chen W; Yang W; Chen P; Huang Y; Li F
    ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
    Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
    Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface Decoration via Physical Interaction of Cupric Diethyldithiocarbamate Nanocrystals and Its Impact on Biodistribution and Tumor Targeting.
    Meng Z; Wang H; Fang X; Liu Z; Yang Z; Yong J; Yang Q; Bai Y; Ren H; Xu H; Li X
    ACS Appl Mater Interfaces; 2021 Aug; 13(31):36894-36908. PubMed ID: 34328715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol-induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET.
    Buchtova T; Skrott Z; Chroma K; Rehulka J; Dzubak P; Hajduch M; Lukac D; Arampatzis S; Bartek J; Mistrik M
    Mol Oncol; 2022 Apr; 16(7):1541-1554. PubMed ID: 34632694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway.
    Majera D; Skrott Z; Chroma K; Merchut-Maya JM; Mistrik M; Bartek J
    Cells; 2020 Feb; 9(2):. PubMed ID: 32085572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow.
    Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y
    ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram-loaded CuO
    Hu W; Yang L; Liao H; Sun D; Ouyang XK; Wang N; Yang G
    J Colloid Interface Sci; 2024 Nov; 674():9-18. PubMed ID: 38908062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the accumulation of disulfiram and its copper complex in A549 cells using mass spectrometry.
    Lu X; Lin B; Xu N; Huang H; Wang Y; Lin JM
    Talanta; 2020 May; 211():120732. PubMed ID: 32070566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram.
    Majera D; Skrott Z; Bouchal J; Bartkova J; Simkova D; Gachechiladze M; Steigerova J; Kurfurstova D; Gursky J; Korinkova G; Cwiertka K; Hodny Z; Mistrik M; Bartek J
    Prostate; 2019 Mar; 79(4):352-362. PubMed ID: 30499118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy.
    Zhou J; Yu Q; Song J; Li S; Li XL; Kang BK; Chen HY; Xu JJ
    Angew Chem Int Ed Engl; 2023 Mar; 62(12):e202213922. PubMed ID: 36585379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buffet-style Cu(II) for enhance disulfiram-based cancer therapy.
    Zhao L; Wang X; Lou H; Jiang M; Wu X; Qin J; Zhang J; Guan X; Li W; Zhang W; Ma J
    J Colloid Interface Sci; 2022 Oct; 624():734-746. PubMed ID: 35696791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.